For many weeks IMGG has proven to be a top volume leader. Through it’s ups and downs it still proves itself in the end. Although down today, IMGG, has the history of coming back on top. IMGG is still one hot stock.
IMGG in the first nine months of 2009 had a total revenue of $799,243 compared to $1,407,424 for the same period in 2008, which represents a 56% decrease. The decrease in revenue is due in part to IMGG focusing on obtaining approval for its new proprietary medical device but the Imaging3, Inc. intends to refocus on the marketing, sale and provision of its historic products and services as well. IMGG’s equipment sales were $375,264 in the first nine months of 2009, compared to $1,058,768 during the same period in 2008, representing a decrease in equipment sales of $1,023,504 in 2009. Service and parts sales for the first nine months of 2009 were $250,750 compared to $211,407 during the same period in 2008.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter
Imaging3, Inc. (Imaging3) is a medical device manufacturer, distributor and third-party service provider. The Company has developed a technology, known as Dominion, which utilizes photo-fluoroscopy to produce three dimensional (3D) medical diagnostic images in real time. Imaging3 is also a remanufacturer of C-arms. The Company offers new, demonstration, remanufactured, refurbished and pre-owned systems in all price ranges from every manufacturer, including OEC, General Electric (GE), ISI, Philips, Siemens, FluoroScan, XiScan and Ziehm. The Company supplies full-size, compact and mini C-arms.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
